BACKGROUND AND AIMS: Elevated alanine aminotransferase (ALT >40 IU/mL) is a marker of liver injury but provides little insight into etiology. We aimed to identify and stratify risk factors associated with elevated ALT in a randomly selected population with a high prevalence of elevated ALT (39%), obesity (49%) and diabetes (30%). METHODS: Two machine learning methods, the support vector machine (SVM) and Bayesian logistic regression (BLR), were used to capture risk factors in a community cohort of 1532 adults from the Cameron County Hispanic Cohort (CCHC). A total of 28 predictor variables were used in the prediction models. The recently identified genetic marker rs738409 on the PNPLA3 gene was genotyped using the Sequenom iPLEX assay. RESULTS: The four major risk factors for elevated ALT were fasting plasma insulin level and insulin resistance, increased BMI and total body weight, plasma triglycerides and non-HDL cholesterol, and diastolic hypertension. In spite of the highly significant association of rs738409 in females, the role of rs738409 in the prediction model is minimal, compared to other epidemiological risk factors. Age and drug and alcohol consumption were not independent determinants of elevated ALT in this analysis. CONCLUSIONS: The risk factors most strongly associated with elevated ALT in this population are components of the metabolic syndrome and point to nonalcoholic fatty liver disease (NAFLD). This population-based model identifies the likely cause of liver disease without the requirement of individual pathological diagnosis of liver diseases. Use of such a model can greatly contribute to a population-based approach to prevention of liver disease.
BACKGROUND AND AIMS: Elevated alanine aminotransferase (ALT >40 IU/mL) is a marker of liver injury but provides little insight into etiology. We aimed to identify and stratify risk factors associated with elevated ALT in a randomly selected population with a high prevalence of elevated ALT (39%), obesity (49%) and diabetes (30%). METHODS: Two machine learning methods, the support vector machine (SVM) and Bayesian logistic regression (BLR), were used to capture risk factors in a community cohort of 1532 adults from the Cameron County Hispanic Cohort (CCHC). A total of 28 predictor variables were used in the prediction models. The recently identified genetic marker rs738409 on the PNPLA3 gene was genotyped using the Sequenom iPLEX assay. RESULTS: The four major risk factors for elevated ALT were fasting plasma insulin level and insulin resistance, increased BMI and total body weight, plasma triglycerides and non-HDL cholesterol, and diastolic hypertension. In spite of the highly significant association of rs738409 in females, the role of rs738409 in the prediction model is minimal, compared to other epidemiological risk factors. Age and drug and alcohol consumption were not independent determinants of elevated ALT in this analysis. CONCLUSIONS: The risk factors most strongly associated with elevated ALT in this population are components of the metabolic syndrome and point to nonalcoholic fatty liver disease (NAFLD). This population-based model identifies the likely cause of liver disease without the requirement of individual pathological diagnosis of liver diseases. Use of such a model can greatly contribute to a population-based approach to prevention of liver disease.
Authors: Zhi Wei; Kai Wang; Hui-Qi Qu; Haitao Zhang; Jonathan Bradfield; Cecilia Kim; Edward Frackleton; Cuiping Hou; Joseph T Glessner; Rosetta Chiavacci; Charles Stanley; Dimitri Monos; Struan F A Grant; Constantin Polychronakos; Hakon Hakonarson Journal: PLoS Genet Date: 2009-10-09 Impact factor: 5.917
Authors: Xin Yuan; Dawn Waterworth; John R B Perry; Noha Lim; Kijoung Song; John C Chambers; Weihua Zhang; Peter Vollenweider; Heide Stirnadel; Toby Johnson; Sven Bergmann; Noam D Beckmann; Yun Li; Luigi Ferrucci; David Melzer; Dena Hernandez; Andrew Singleton; James Scott; Paul Elliott; Gerard Waeber; Lon Cardon; Timothy M Frayling; Jaspal S Kooner; Vincent Mooser Journal: Am J Hum Genet Date: 2008-10 Impact factor: 11.025
Authors: Stefano Romeo; Julia Kozlitina; Chao Xing; Alexander Pertsemlidis; David Cox; Len A Pennacchio; Eric Boerwinkle; Jonathan C Cohen; Helen H Hobbs Journal: Nat Genet Date: 2008-09-25 Impact factor: 38.330
Authors: Ariana L Garza; Kristina P Vatcheva; Jen-Jung Pan; Mohammad H Rahbar; Michael B Fallon; Joseph B McCormick; Susan P Fisher-Hoch Journal: J Racial Ethn Health Disparities Date: 2015-03-28
Authors: Quan Li; Hui-Qi Qu; Anne R Rentfro; Megan L Grove; Shaper Mirza; Yang Lu; Craig L Hanis; Michael B Fallon; Eric Boerwinkle; Susan P Fisher-Hoch; Joseph B McCormick Journal: Clin Invest Med Date: 2012-08-04 Impact factor: 0.825
Authors: Elena Larrieta-Carrasco; Victor Acuña-Alonzo; Rafael Velázquez-Cruz; Rodrigo Barquera-Lozano; Paola León-Mimila; Hugo Villamil-Ramírez; Marta Menjivar; Sandra Romero-Hidalgo; Nahúm Méndez-Sánchez; Vanessa Cárdenas; Manuel Bañuelos-Moreno; Yvonne N Flores; Manuel Quiterio; Jorge Salmerón; Fausto Sánchez-Muñoz; Teresa Villarreal-Molina; Carlos A Aguilar-Salinas; Samuel Canizales-Quinteros Journal: Mol Biol Rep Date: 2014-04-02 Impact factor: 2.316